Previous 10 | Next 10 |
home / stock / exas / exas articles
Exact Sciences Corp (NASDAQ: EXAS) filed a patent infringement lawsuit against Geneoscopy in the U.S. District Court for the District of ...
Stocks experienced a modest surge amid the Federal Open Market Committee meeting Wednesday. The central bank is widely expected to leave interest r...
The see-sawing sentiment continues as index futures pull back ahead of the all-important rate decision from the Federal Reserve. Some negative earn...
On CNBC’s "Mad Money Lightning Round," Jim Cramer said CVS Health Corporation (NYSE: CVS) is a retailer that has a healthcare bus...
On Tuesday, Cathie Wood-led Ark Invest made significant trades, with a notable purchase of shares in Robinhood Markets Inc (NASDAQ:HOOD) while offl...
Shares of Exact Sciences Corp (NASDAQ: EXAS) were climbing in early trading on Tuesday, ahead of the company’s third-quarter earnings call. T...
In response to the escalating spread of the virus nationwide, the Biden administration declared that it would recommence offering free at-home COVI...
With a track record of 60-plus years of strong returns for investors, Warren Buffett, who turns 93 Wednesday, is considered one of the al...
On Monday, Cathie Wood-led Ark Invest made a significant move by continuing its buying spree of Archer Aviation Inc (NASDAQ:ACHR) shares. The inve...
News, Short Squeeze, Breakout and More Instantly...
Exact Sciences Corporation Company Name:
EXAS Stock Symbol:
NASDAQ Market:
Exact Sciences Corporation Website:
2024-06-26 18:30:02 ET Scotiabank analyst issues OUTPERFORM recommendation for EXAS on June 26, 2024 04:27PM ET. EXAS was trading at $44.16 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current analyst recommendations are : 1 - Strong Buy, ...
2024-06-26 18:00:04 ET Sung Ji Nam from Scotiabank issued a price target of $70.00 for EXAS on 2024-06-26 16:27:00. The adjusted price target was set to $70.00. At the time of the announcement, EXAS was trading at $44.16. The overall price target consensus is at $96.29 w...
2024-06-26 09:15:03 ET BTIG analyst issues BUY recommendation for EXAS on June 26, 2024 07:41AM ET. The previous analyst recommendation was Buy. EXAS was trading at $41.37 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current analyst re...